Triptorelin
Back to searchMolecule Structure
Scientific Name
Triptorelin
Description of the Drug
Triptorelin is a GnRH agonist indicated for the palliative treatment of advanced prostate cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06825
http://www.drugbank.ca/drugs/DB06825
Brand Name(s)
Decapeptyl, Decapeptyl sr, Gonapeptyl depot
Company Owner(s)
Azurity Pharmaceuticals Inc, Verity Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Gonadotropin-releasing hormone receptor | SINGLE PROTEIN | AGONIST | CHEMBL1855 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL22289009 | SCHEMBL5079698 | |
| DrugBank | DB06825 | ||
| PubChem: Thomson Pharma | 14817278 | 14768412 | 14817279 |
| PubChem | 25074470 | ||
| LINCS | LSM-46025 | ||
| Nikkaji | J33.170H | ||
| DrugCentral | 2968 | ||
| Guide to Pharmacology | 1177 | ||
| rxnorm | TRIPTORELIN PAMOATE | TRELSTAR | TRIPTORELIN |
| PubChem: Drugs of the Future | 12012926 | ||
| ChEBI | 63633 |
